Masters candidate in Oncology at USP (ICESP), researching viral vector genetic engineering; holds a BSc in Biotechnology from UFAM with expertise in molecular and synthetic biology applied to cancer gene therapy. Served as Scientific Consultant at Uniscience Corporation and collaborated with LACEN/AM (RT-qPCR COVID-19 diagnostics) and FCECON (studies on oncogenic viruses in thyroid neoplasms and the molecular and clinical profiling of colorectal cancer). Was Counselor for the Amazonas chapter of the National League of Biotechnology Academics and served as both team member and judge for Human Practices at iGEM Boston; also worked as Regulatory Affairs Advisor for the Brazilian Association of Synthetic Biology. Research interests include Molecular Biology, Molecular Oncology, Genetic Engineering, and Synthetic Biology. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
One of the goals for cancer treatment is the induction of oncolysis and antitumor immune response. For example, radiotherapy and chemotherapy drugs are known to induce immunogenic death. In the same way, gene therapy can also be used for this purpose, such as using oncolytic viruses, whether by the action of viral replication or the function of transgenes encoded by the vector. Previous w…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID